首页 / 院系成果 / 成果详情页

Silencing of tumor suppressor IGFBP4 constitutes EZH2-driven epigenetic reprogramming in hepatocarcinogenesis  会议论文 期刊论文  

  • 编号:
    053bc3a8-e636-4b01-acf3-1082988eb561
  • 作者:
    Mok, Myth T.[1] Lee, YingYing[1,2] Kang, Wei[3] Yang, Weiqin[1] Tang, Wenshu[1] Wu, Feng[1] Xu, Liangliang[1] Yu, Zhuo[4] Lee, SauDan[5] Wong, Grace L. H.[2] Yip, Kevin Y. L.[5] To, KaFai[3,6] Cheng, Alfred S. L.[1,6]
  • 语种:
    英文
  • 期刊:
    CANCER SCIENCE ISSN:1349-7006 2018 年 109 卷 (235 - 235) ; DEC
  • 收录:
  • 推荐引用方式
    GB/T 7714:
    Mok Myth T.,Lee Ying-Ying,Kang Wei, et al. Silencing of tumor suppressor IGFBP4 constitutes EZH2-driven epigenetic reprogramming in hepatocarcinogenesis [J].CANCER SCIENCE,2018,109:235-235.
  • APA:
    Mok Myth T.,Lee Ying-Ying,Kang Wei,Yang Weiqin,&Cheng Alfred S. L..(2018).Silencing of tumor suppressor IGFBP4 constitutes EZH2-driven epigenetic reprogramming in hepatocarcinogenesis .CANCER SCIENCE,109:235-235.
  • MLA:
    Mok Myth T., et al. "Silencing of tumor suppressor IGFBP4 constitutes EZH2-driven epigenetic reprogramming in hepatocarcinogenesis" .CANCER SCIENCE 109(2018):235-235.
浏览次数:42 下载次数:0
浏览次数:42
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部